A wrongful death lawsuit has been filed on behalf of a Missouri woman who allegedly died after undergoing a laparoscopic hysterectomy and uterine fibroid removal surgery with an Ethicon power morcellator. The complaint comes just weeks after the U.S. Food & Drug Administration (FDA) warned that morcellators should not be used on the vast majority of women for fibroid removal surgery.
Free Morcellator Cancer Lawsuit Evaluation: If you or a loved one was diagnosed with cancer after undergoing surgery with a laparoscopic power morcellator, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of the morcellator and we can help.
What’s the Problem?
According to court documents, Ms. Carl Cecilia Merrill had her uterus and fibroids laparoscopically removed with an Ethicon Gynecare power morcellator in December 2012. The device allegedly spread previously undetected cancerous tissue throughout her peritoneal cavity, causing a rapid upstaging of the disease from its most treatable stage to the most deadly. As a result, Merrill died of metastatic uterine cancer in August 2014.
The FDA first warned about the dangers associated with power morcellators in April 2014, stating that approximately 1 in 350 women who require hysterectomy or myomectomy surgery have an undiagnosed form of uterine cancer called uterine sarcoma. If morcellation is performed in these women, there is a risk that the procedure will spread cancerous tissue to other parts of the body.
“When used for hysterectomy or myomectomy in women with uterine fibroids, laparoscopic power morcellation poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus,” FDA said. “Health care providers and patients should carefully consider available alternative treatment options for symptomatic uterine fibroids. Based on currently available information, the FDA discourages the use of laparoscopic power morcellation during hysterectomy or myomectomy for uterine fibroids.”
On Nov. 24, FDA updated the warning, recommending that manufacturers of power morcellators include a “boxed warning” on their products’ labeling, and to detail specific cases in which their devices should not be used.
“The FDA’s primary concern is the safety and well-being of patients and taking these steps will help the agency’s safety recommendations to be implemented as quickly as possible,” said William Maisel, M.D., M.P.H., deputy director for science and chief scientist at the FDA’s Center for Devices and Radiological Health. “Updating the device label with a boxed warning and contraindications will provide clinicians and patients with critical information about the risk of spreading cancerous tissue when these procedures are performed.”
Do I Have a Morcellator Cancer Lawsuit?
The Medical Device Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in laparoscopic power morcellator lawsuits. We are handling individual litigation nationwide and currently accepting new morcellation cancer cases in all 50 states.
Free Morcellator Cancer Lawsuit Evaluation: If you or a loved one was diagnosed with cancer after undergoing surgery with a laparoscopic power morcellator, you should contact our law firm immediately. You may be entitled to compensation by filing a Morcellation Cancer Suit and we can help.